| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/06/2008 | CN101116743A Cold treating medicine |
| 02/06/2008 | CN101116738A Chinese traditional medicine for treating mammary gland hyperplasia and method for preparing the same |
| 02/06/2008 | CN101116688A Compound oil for treating empyrosis and skin infection and method for preparation thereof |
| 02/06/2008 | CN101116682A Chinese traditional medicine special for treating chilblain |
| 02/06/2008 | CN101116679A Chinese traditional medicine special for treating mild chilblain |
| 02/06/2008 | CN101116670A Application of compound capable of providing active methyl or of taking part in the diversion of methyl in the preparation of medicine for treating virosis |
| 02/06/2008 | CN101116669A 20(R)-ginsenoside composition and uses thereof |
| 02/06/2008 | CN101116668A Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients proteurs de cancers multiples |
| 02/06/2008 | CN101116667A Medicine for treating and preventing immune abnormalism disease |
| 02/06/2008 | CN101116666A Compositions of estrogen-cyclodextrin complexes |
| 02/06/2008 | CN101116665A Malaria-resisting arteannuin naphthoquine compound composition |
| 02/06/2008 | CN101116664A Application of compound 1-( 4-chloroaniline )-4-( 4-picoline )-2, 3-naphthyridine |
| 02/06/2008 | CN101116663A Percutaneously absorbable preparation for treating male sexual disfunction and method for preparing the same |
| 02/06/2008 | CN101116662A Application of sophocarpine in the preparation of medicine for treating adenovirus-caused inflammation |
| 02/06/2008 | CN101116661A Application of 5-hydroxymethyl furfural in the preparation of medicine for protecting vascellum endothelial cell |
| 02/06/2008 | CN101116660A Use of compound for resisting atherosis thrombosis in the obtaining of medicine for treating vascellum disease |
| 02/06/2008 | CN101116659A Eplerenone soft capsule preparations and method for preparing the same |
| 02/06/2008 | CN101116658A Eplerenone liquid capsule preparations and method for preparing the same |
| 02/06/2008 | CN101116656A Ciclopirox olamine gelling agent, method for preparing the same and pharmaceutical use thereof |
| 02/06/2008 | CN101116512A Enteral feeding solutions contain an alkyl paraben to inhibit growth of micro-organisms in the enteral tube |
| 02/06/2008 | CN100366630C Preparation of suaveolic flavone for treating chronic pharyngitis and chronic tonsilltiis |
| 02/06/2008 | CN100366629C Technique for preparing pharmaceutical product of í«Denghuayisuí» in high purity |
| 02/06/2008 | CN100366628C Effective parts of fructus sophorae flavone production and use thereof |
| 02/06/2008 | CN100366624C 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles |
| 02/06/2008 | CN100366622C 20(S) camptotheca alkaloid derivatives, their preparing methods and uses |
| 02/06/2008 | CN100366620C Process for the preparation of 4-(8-chloro-5,6-dihydro-11h-benzo(5,6)-cyclohepta-(1,2b)-pyridin-11-ylidene)-1-piperidinecarboxyli c acid ethyl ester (loratadine) |
| 02/06/2008 | CN100366618C Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 02/06/2008 | CN100366616C Novel bicyclic inhibitors of hormone sensitive lipase |
| 02/06/2008 | CN100366614C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 02/06/2008 | CN100366612C 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as aspartic specifity cysteine proteinase inhibitors |
| 02/06/2008 | CN100366611C Substitutional ramification of tetrahydro-isoquinoline, as well as its preparing method and its medication compound containing them |
| 02/06/2008 | CN100366606C New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/06/2008 | CN100366296C Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 02/06/2008 | CN100366289C Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 02/06/2008 | CN100366288C Dental ulcerative glue |
| 02/06/2008 | CN100366282C Medicinal compositions comprising biphenyldicarboxylate |
| 02/06/2008 | CN100366268C Plant essence with equalized fat acids |
| 02/06/2008 | CN100366266C Medicine for treating Acne and its preparing method |
| 02/06/2008 | CN100366264C Cornel extract and use thereof |
| 02/06/2008 | CN100366261C Skin material for external use and antiprutiric agent for external use and wrinkle-reducing instrument using the same |
| 02/06/2008 | CN100366260C Astragalus glycoside fatty emulsion and its preparation technology |
| 02/06/2008 | CN100366259C Application of general saponin of gen-seng fruit in the preparation process of myocarditis treating medicine |
| 02/06/2008 | CN100366258C Application of ursane type triterpenoid saponin in the preparing process of leucocyte and/or platelet increasing medicine |
| 02/06/2008 | CN100366257C Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 02/06/2008 | CN100366256C Ciclesonide-containing sterile aqueous suspension |
| 02/06/2008 | CN100366255C Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents |
| 02/06/2008 | CN100366254C Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases |
| 02/06/2008 | CN100366253C 1,2,4-benzotriazine oxides formulations |
| 02/06/2008 | CN100366252C N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion |
| 02/06/2008 | CN100366251C Organic compounds |
| 02/06/2008 | CN100366250C Freeze dried vinpocetine powder injection and its preparation process |
| 02/06/2008 | CN100366249C Control releasing administration system for temozolomide |
| 02/06/2008 | CN100366248C Skin care composition for mediating cell to cell communication |
| 02/06/2008 | CN100366247C Single nitrate isosorbide delayed-release tablets |
| 02/06/2008 | CN100366246C Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits |
| 02/06/2008 | CN100366245C Oil from momordica charantia L., its method of preparation and uses |
| 02/06/2008 | CN100366244C Local used composition containing antifungal agent |
| 02/06/2008 | CN100366243C Process for preparation of dispersions |
| 02/06/2008 | CN100366242C Non-dropped medicine releaser in vagina and its preparation and use |
| 02/06/2008 | CN100366241C Use of an IBAT inhibitor for the treatment of prophylaxis of constipation. |
| 02/06/2008 | CN100366240C Ultraviolet-shielding type patch |
| 02/06/2008 | CN100366239C Soft capsules |
| 02/06/2008 | CN100366238C Freeze dried polyene lecithin powder for injection and its prepn |
| 02/05/2008 | USRE40045 Combined preparation of salmeterol or a salt (1-hydroxy-2-naphthalenecarboxylate salt) and fluticasone propionate for simultaneous, sequential or separate administration by inhalation in the treatment of respiratory disorders |
| 02/05/2008 | US7326812 Arylsulfonamidobenzylic compounds |
| 02/05/2008 | US7326801 2-amino-propanol derivatives |
| 02/05/2008 | US7326794 Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
| 02/05/2008 | US7326792 4,5-Diphenyl-2-amino-4,5-dihydro-imidazole derivatives useful as pharmaceutical agents in treatment or prevention of diseases having an inflammatory component, including inflammatory bowel disease, rheumatoid arthritis and diseases associated with central nervous system, such as Alzheimer's disease |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326790 Diphenylisoxazole compounds and hydro isomers thereof |
| 02/05/2008 | US7326789 E.g., 2-(4-Chloro-phenylsufonylamino)-4,5-dimethoxy-N-(4-(thiomorpholine-4-sulfonyl)-phenyl)-benzamide; cardiovascular disorders; hypotensive agents; angina pectoris, cardiac insufficiency, thrombolytic agents; atherosclerosis; activating soluble guanylate cyclase to adjust a disturbed cyclic GMP balance |
| 02/05/2008 | US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide |
| 02/05/2008 | US7326783 Genetic engineering |
| 02/05/2008 | US7326735 Formulations for anaesthetic use |
| 02/05/2008 | US7326734 Treatment of bladder and urinary tract cancers |
| 02/05/2008 | US7326733 Methods for increasing bone density |
| 02/05/2008 | US7326732 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders |
| 02/05/2008 | US7326731 Muscarinic agonists |
| 02/05/2008 | US7326730 Aminoadamantane derivatives as therapeutic agents |
| 02/05/2008 | US7326729 CXCR1 and CXCR2 chemokine antagonists |
| 02/05/2008 | US7326728 Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof |
| 02/05/2008 | US7326727 Furanthiazole derivatives as heparanase inhibitors |
| 02/05/2008 | US7326726 Biaryl substituted triazoles as sodium channel blockers |
| 02/05/2008 | US7326724 Salts of omeprazole and esomeprazole I |
| 02/05/2008 | US7326723 Autoimmune disease; antiinflammatory agents |
| 02/05/2008 | US7326722 N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives, their preparation and their application in therapy |
| 02/05/2008 | US7326721 Doxepin analogs and methods of use thereof |
| 02/05/2008 | US7326720 Phenyl- and pyridylpiperidines with TNF activity |
| 02/05/2008 | US7326719 Cathepsin S inhibitors |
| 02/05/2008 | US7326718 8-Substituted imidazopyridines |
| 02/05/2008 | US7326717 Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof |
| 02/05/2008 | US7326716 Treatment of inflammatory bowel disease |
| 02/05/2008 | US7326715 4-Phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives |
| 02/05/2008 | US7326714 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 02/05/2008 | US7326713 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
| 02/05/2008 | US7326712 Substituted tricyclic compounds as protein kinase inhibitors |
| 02/05/2008 | US7326711 Antiproliferative agents for humans, animals |
| 02/05/2008 | US7326710 Aralkyl formyl-alkyl piperazine derivatives and their uses as a cerebral nerve protective agent |
| 02/05/2008 | US7326709 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder |